Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-28

Clinical Trial Update: Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of mirabegron for intracerebral hemorrhage is currently recruiting at Tianjin Medical University Gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Myrbetriq (mirabegron)

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: Intracerebral Haemorrhage | Phase 2 | Status: RECRUITING